These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 410476)
1. A vaccine against gonorrhoea? Br Med J; 1977 Oct; 2(6092):917-8. PubMed ID: 410476 [No Abstract] [Full Text] [Related]
2. [Some aspects of the study of gonorrhea vaccine]. He F; Zhao L Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):248-50. PubMed ID: 10322765 [No Abstract] [Full Text] [Related]
3. [Ways and prospects of producing gonococcal vaccine]. Bednova VN; Dmitriev GA; Pasternak NI Vestn Dermatol Venerol; 1987; (11):41-7. PubMed ID: 3125694 [No Abstract] [Full Text] [Related]
4. Preliminary studies on the development of a gonococcal vaccine. Greenberg I; Diena BB; Kenny CP; Znamirowski R Bull World Health Organ; 1971; 45(4):531-5. PubMed ID: 5004708 [No Abstract] [Full Text] [Related]
5. Characterization of a gonococcal cell-wall lectin-adhesin with vaccine potential. Perrollet H; Guinet RM Ann Sclavo Collana Monogr; 1986; 3(1-2):399-406. PubMed ID: 3122804 [No Abstract] [Full Text] [Related]
6. Type-14 pneumococcal vaccine for prevention of gonorrhoea. Diena BB; Ashton FE; Perry MB Lancet; 1979 May; 1(8124):1037. PubMed ID: 86759 [No Abstract] [Full Text] [Related]
7. Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccine. Semchenko EA; Seib KL Sex Transm Infect; 2016 Dec; 92(8):561-562. PubMed ID: 27037185 [No Abstract] [Full Text] [Related]
8. Could vaccination against Neisseria gonorrhoeae be on the horizon? Russell MW Future Microbiol; 2018 Apr; 13():495-497. PubMed ID: 29517283 [No Abstract] [Full Text] [Related]
9. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap. Gottlieb SL; Jerse AE; Delany-Moretlwe S; Deal C; Giersing BK Sex Health; 2019 Sep; 16(5):426-432. PubMed ID: 31476278 [TBL] [Abstract][Full Text] [Related]
10. Vaccine research for gonococcal infections: where are we? Jerse AE; Deal CD Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883 [TBL] [Abstract][Full Text] [Related]
11. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies. Wetzler LM; Blake MS; Gotschlich EC Trans Assoc Am Physicians; 1989; 102():78-90. PubMed ID: 2561644 [No Abstract] [Full Text] [Related]
16. The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial. White PJ; Leng T; Nikitin D; Whittles LK Lancet Infect Dis; 2024 Sep; 24(9):e543. PubMed ID: 39032496 [No Abstract] [Full Text] [Related]
17. [Pyrogenal-vaccine therapy of men with gonorrhea]. Shamshin NF; Malykh VA Vestn Dermatol Venerol; 1980 Nov; (11):62-4. PubMed ID: 6778014 [No Abstract] [Full Text] [Related]
18. Gonococcal vaccine studies in Inuvik. Greenberg L; Diena BB; Ashton FA; Wallace R; Kenny CP; Znamirowski R; Ferrari H; Atkinson J Can J Public Health; 1974; 65(1):29-33. PubMed ID: 4205640 [No Abstract] [Full Text] [Related]
19. The inability of Neisseria gonorrhoeae pili antibodies to confer immunity in subcutaneous guinea-pig chambers. Turner WH; Novotny P J Gen Microbiol; 1976 Jan; 92(1):224-8. PubMed ID: 812949 [No Abstract] [Full Text] [Related]
20. Some perspectives on the problem of gonorrhea. Weiler PG; Maddox DE J Ky Med Assoc; 1977 Jan; 75(1):16-20, 49. PubMed ID: 401857 [No Abstract] [Full Text] [Related] [Next] [New Search]